Peptide Atlas · Peptide

Nafarelin

Nafarelin is a GnRH agonist given as a nasal spray; in a six-month double-blind trial in 213 women with endometriosis it reduced disease extent at laparoscopy as much as oral danazol, with hot flashes rather than the adverse lipid changes seen with danazol.

established

provisional
PubChem 25077405
1 citation
0 discussions
0 followers
D-Nal(2)6-LHRH
Nafarelin acetate
Synarel

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

No trial registration is cited for it. A registered trial cites as an NCT number and resolves through ClinicalTrials.gov.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.